CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
specialized tumor board recommendationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02060890
NCT02060890N/ACompleted
CompareCT.gov

A Pilot Trial Testing the Feasibility of Using Molecular Profiling to Guide an Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma

University of California, San Francisco·observational·Posted Feb 12, 2014·Updated Dec 12, 2023

In Brief

An observational study evaluating specialized tumor board recommendation for Adult Glioblastoma. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This current study will use a new treatment approach based on each patient's tumor genomic profiling consisting of whole genome sequencing, exome analysis, and RNA sequencing as well as predictive modeling. This new treatment strategy has shown promising results in adult patients with other solid tumors.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Glioblastoma
CountriesUnited States
CollaboratorsTranslational Genomics Research Institute, The Ben & Catherine Ivy Foundation

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 12, 2014
Enrollment StartAug 1, 2014
Primary CompletionSep 3, 2015
Study CompletionMay 10, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.4 years ago

Interventions

specialized tumor board recommendationother

feasibility of a specialized tumor board to come up with treatment recommendations no later than 35 days from surgery.